Multiple problems are associated with the prognostic markers in CLL. Traditionally, IgVH mutational status was difficult to obtain, but commercial labs have made this test widely available. ZAP-70 testing remains notoriously inconsistent, and no true standard among commercial labs exists. CD38 can be...